Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Justice Department sues CVS subsidiary Omnicare

A CVS Health subsidiary, Omnicare, is facing a lawsuit from the Department of Justice over allegations the company defrauded government health programs by providing prescription drugs to thousands of long-term care facilities without proper prescriptions.

Thumbnail

HHS proposals aim to boost organ donation supply

HHS has issued a set of two proposed rules aimed at improving the availability of organs for the 113,000 Americans on waitlists for transplants.

Thumbnail

Repeal of controversial $20B medical device tax may be imminent

Foes of the tax applauded the proposed spending bill on Tuesday, Dec. 17, urging lawmakers to “cross the finish line.” 

Thumbnail

Leapfrog names the top hospitals of 2019

National watchdog organization The Leapfrog Group has announced its 2019 Top Hospitals awards, offering recognition to the highest quality hospitals in the nation.

Thumbnail

Congress moves to permanently repeal medical device tax

Legislators are expected to pass the bill this week, which will then be sent on to President Trump to sign into law before government funding expires at midnight Friday.

Thumbnail

Intel acquires AI startup for $2B

Intel Corporation has acquired Habana Labs, a Tel-Aviv, Israel-based AI startup founded in 2016, for approximately $2 billion.

Thumbnail

New protocol helps breast cancer patients avoid unnecessary surgery

“This would be a major step toward improving quality of life for patients with breast cancer," said lead investigator Henry Kuerer, MD, PhD. 

Thumbnail

FDA approves icosapent ethyl to reduce CV risk

The FDA has approved Amarin’s Vascepa—icosapent ethyl—to reduce cardiovascular risk beyond cholesterol-lowering therapy in high-risk patients, making it the first drug of its kind to be approved in the U.S.